Global Rare Disease Diagnostics Market by Component (Consumable & Assay Kit, Diagnostic Instrument), Technology (Array Technology, Next Generation Sequencing, Sanger Sequencing), Disease Type, End-use - Forecast 2024-2030- Product Image

Sale

Global Rare Disease Diagnostics Market by Component (Consumable & Assay Kit, Diagnostic Instrument), Technology (Array Technology, Next Generation Sequencing, Sanger Sequencing), Disease Type, End-use - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5925138

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Rare Disease Diagnostics Market size was estimated at USD 2.68 billion in 2023, USD 3.12 billion in 2024, and is expected to grow at a CAGR of 17.36% to reach USD 8.23 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rare Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rare Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rare Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 23andMe Inc., 3billion, Inc., Agilent Technologies Inc., ARCHIMED Life Science GmbH, ARUP Laboratories, AstraZeneca PLC, Azenta Life Sciences, Baylor Genetics, Caris Life Sciences, CENTOGENE N.V., Eurofins Scientific Inc., F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Illumina, Inc., In-Depth Genomics, Invitae Corporation, Laboratory Corporation of America Holdings, MedGenome Labs Ltd, OPKO Health, Inc., PerkinElmer Inc., Progenity, Inc., Quest Diagnostics Incorporated, Sanofi S.A., Thermo Fisher Scientific Inc., and Travere Therapeutics Inc.

Market Segmentation & Coverage

This research report categorizes the Rare Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- Consumable & Assay Kit
- Diagnostic Instrument
Technology
- Array Technology
- Next Generation Sequencing
- Sanger Sequencing
Disease Type
- Cancer
- Cardiovascular Disorders
- Dermatology Disease
- Endocrine & Metabolism Diseases
- Hematology Diseases
- Immunological Disorders
- Musculoskeletal Disorders
- Neurological Disorders
End-use
- Diagnostic Laboratories
- Hospitals & Clinics
- Research Laboratories & CROs

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Rare Disease Diagnostics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rare Disease Diagnostics Market?
What are the technology trends and regulatory frameworks in the Rare Disease Diagnostics Market?
What is the market share of the leading vendors in the Rare Disease Diagnostics Market?
Which modes and strategic moves are suitable for entering the Rare Disease Diagnostics Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Rare Disease Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of rare genetic diseases and the need for early & rapid diagnosis
5.1.1.2. Rising use in translational & genomic research for the identification of novel mutations
5.1.1.3. Government initiatives for diagnosis and treatment of rare diseases
5.1.2. Restraints
5.1.2.1. Stringent regulations associated with the approval process of new rare diseases genetic test
5.1.3. Opportunities
5.1.3.1. Advancements in genetic technology to Identify new rare disease genes
5.1.3.2. Favorable investments for diagnosis of rare genetic diseases
5.1.4. Challenges
5.1.4.1. Ethical concerns and access to limited information on rare disease
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Rare Disease Diagnostics Market, by Component

6.1. Introduction
6.2. Consumable & Assay Kit
6.3. Diagnostic Instrument

7. Rare Disease Diagnostics Market, by Technology

7.1. Introduction
7.2. Array Technology
7.3. Next Generation Sequencing
7.4. Sanger Sequencing

8. Rare Disease Diagnostics Market, by Disease Type

8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Disorders
8.4. Dermatology Disease
8.5. Endocrine & Metabolism Diseases
8.6. Hematology Diseases
8.7. Immunological Disorders
8.8. Musculoskeletal Disorders
8.9. Neurological Disorders

9. Rare Disease Diagnostics Market, by End-use

9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics
9.4. Research Laboratories & CROs

10. Americas Rare Disease Diagnostics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Rare Disease Diagnostics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Rare Disease Diagnostics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. 23andMe Inc.
14.1.2. 3billion, Inc.
14.1.3. Agilent Technologies Inc.
14.1.4. ARCHIMED Life Science GmbH
14.1.5. ARUP Laboratories
14.1.6. AstraZeneca PLC
14.1.7. Azenta Life Sciences
14.1.8. Baylor Genetics
14.1.9. Caris Life Sciences
14.1.10. CENTOGENE N.V.
14.1.11. Eurofins Scientific Inc.
14.1.12. F. Hoffmann-La Roche Ltd.
14.1.13. Fulgent Genetics, Inc.
14.1.14. Illumina, Inc.
14.1.15. In-Depth Genomics
14.1.16. Invitae Corporation
14.1.17. Laboratory Corporation of America Holdings
14.1.18. MedGenome Labs Ltd
14.1.19. OPKO Health, Inc.
14.1.20. PerkinElmer Inc.
14.1.21. Progenity, Inc.
14.1.22. Quest Diagnostics Incorporated
14.1.23. Sanofi S.A.
14.1.24. Thermo Fisher Scientific Inc.
14.1.25. Travere Therapeutics Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. RARE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. RARE DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. RARE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RARE DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 12. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RARE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RARE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. RARE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RARE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 9. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY ARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 13. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOLOGY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOCRINE & METABOLISM DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 22. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RARE DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 39. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 73. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 97. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 126. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM RARE DISEASE DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 193. RARE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 194. RARE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. RARE DISEASE DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

23andMe Inc.
3billion, Inc.
Agilent Technologies Inc.
ARCHIMED Life Science GmbH
ARUP Laboratories
AstraZeneca PLC
Azenta Life Sciences
Baylor Genetics
Caris Life Sciences
CENTOGENE N.V.
Eurofins Scientific Inc.
F. Hoffmann-La Roche Ltd.
Fulgent Genetics, Inc.
Illumina, Inc.
In-Depth Genomics
Invitae Corporation
Laboratory Corporation of America Holdings
MedGenome Labs Ltd
OPKO Health, Inc.
PerkinElmer Inc.
Progenity, Inc.
Quest Diagnostics Incorporated
Sanofi S.A.
Thermo Fisher Scientific Inc.
Travere Therapeutics Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.12 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.23 Billion
Compound Annual Growth Rate	17.3%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Rare Disease Diagnostics Global Market Report 2024

Rare Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Japan Rare Disease Diagnostics Market, Competition, Forecast & Opportunities, 2018-2028

Omics Technologies for Clinical Diagnosis and Gene Therapy: Medical Applications in Human Genetics

Technology Advancements in Precision Diagnostics and Testing